These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 556116)

  • 1. [Clinical pharmacology and rational therapeutic use of antidiabetic drugs].
    Giraudo JR
    Rev Fac Cien Med Univ Nac Cordoba; 1979; 37(1-4):28-33. PubMed ID: 556116
    [No Abstract]   [Full Text] [Related]  

  • 2. Clinical use of oral hypoglycemic agents.
    Hagg SA
    Am J Hosp Pharm; 1976 Sep; 33(9):943-7. PubMed ID: 790951
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antidiabetic drugs after the University Group Diabetes Program (UGDP).
    Karam JH; Matin SB; Forsham PH
    Annu Rev Pharmacol; 1975; 15():351-66. PubMed ID: 1096790
    [No Abstract]   [Full Text] [Related]  

  • 4. Oral hypoglycaemic drugs: clinical pharmacology and therapeutic use.
    Stowers JM; Borthwick LJ
    Drugs; 1977 Jul; 14(1):41-56. PubMed ID: 328260
    [No Abstract]   [Full Text] [Related]  

  • 5. Biguanides. Mode of action and role in the up-to-date treatment of diabetes mellitus.
    Fövényi J
    Ther Hung; 1971; 19(2):43-8. PubMed ID: 5172874
    [No Abstract]   [Full Text] [Related]  

  • 6. [Thyroid function in diabetics treated with sulfonylurea and biguanides].
    Kasperska-Czyzykowa T; Czech W; Sawicki Z; Woy-Wojciechowski J; Zuławnik W
    Pol Arch Med Wewn; 1978 Mar; 59(3):275-83. PubMed ID: 580962
    [No Abstract]   [Full Text] [Related]  

  • 7. Oral agents for the treatment of type 2 diabetes mellitus: pharmacology, toxicity, and treatment.
    Harrigan RA; Nathan MS; Beattie P
    Ann Emerg Med; 2001 Jul; 38(1):68-78. PubMed ID: 11423816
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Oral hypoglycemic agents.
    Shen SW; Bressler R
    Dis Mon; 1976 Jan; 22(4):1-35. PubMed ID: 765082
    [No Abstract]   [Full Text] [Related]  

  • 9. Effect of oral antidiabetic drugs on lipase activity in vitro.
    Holmes JH; Sapeika N; Zwarenstein H
    Res Commun Chem Pathol Pharmacol; 1975 Aug; 11(4):667-70. PubMed ID: 1179037
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Actual problems of the hypoglycaemic sulfonylureas.
    Káldor A
    Ther Hung; 1977; 25(2):47-50. PubMed ID: 898117
    [No Abstract]   [Full Text] [Related]  

  • 11. [The pharmacological blockade of protein glycosylation in diabetes mellitus using sulfonylurea derivatives and biguanides].
    Lebedeva EA
    Eksp Klin Farmakol; 1996; 59(5):40-2. PubMed ID: 9026209
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacology of antihyperglycemic drugs.
    Marble A
    N Y State J Med; 1972 Sep; 72(17):2174-8. PubMed ID: 4560042
    [No Abstract]   [Full Text] [Related]  

  • 13. Hepatic effects of oral hypoglycemic drugs.
    Davidoff F
    Fed Proc; 1977 Dec; 36(13):2724-7. PubMed ID: 336410
    [No Abstract]   [Full Text] [Related]  

  • 14. [Pharmacologic profile of oral antidiabetic agents].
    Okubo M; Yamane K; Kohno N
    Nihon Rinsho; 2002 Sep; 60 Suppl 9():310-6. PubMed ID: 12387011
    [No Abstract]   [Full Text] [Related]  

  • 15. [Pharmacology and therapeutics: oral antidiabetic agents - usage and current trends].
    Beltrán Lendinez M; Parras Puche M; Liebanas Pegalajar C; García Jiménez JA
    Rev Enferm; 1982 Feb; 5(44):13-8. PubMed ID: 7041228
    [No Abstract]   [Full Text] [Related]  

  • 16. Anti-diabetic agents.
    Biron CR
    RDH; 1995 May; 15(5):32-4. PubMed ID: 10332415
    [No Abstract]   [Full Text] [Related]  

  • 17. Oral hypoglycemic agents: the pharmacological basis of their clinical use.
    Davidoff F
    R I Med J; 1973 Oct; 56(10):409-14. PubMed ID: 4518221
    [No Abstract]   [Full Text] [Related]  

  • 18. [Behavior of serum insulin under the influence of glisoxepide with and without butylbiguanide].
    Birk W; Petrides P
    Arzneimittelforschung; 1974 Mar; 24(0):425-9. PubMed ID: 4408033
    [No Abstract]   [Full Text] [Related]  

  • 19. [Clinically important effects of oral antidiabetic drug interactions].
    Drzewoski J; Kopff B
    Pol Merkur Lekarski; 2000 Sep; 9(51):605-7. PubMed ID: 11126985
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sulphonylureas and biguanides do not affect insulin binding in H35 hepatoma cells.
    De Vries CP; van der Veen EA
    Diabetes Res; 1986 Jul; 3(6):307-10. PubMed ID: 3757414
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.